Income Statement Kymera Therapeutics, Inc.

Equities

KYMR

US5015751044

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 17/04/2026 BST			5-day change	1st Jan Change
87.71 ^USD	+1.82%		+3.13%	+12.72%

04-13	Kymera Therapeutics Wins FDA Fast Track for Oral Asthma Drug	MT
04-13	Kymera Therapeutics, Inc. Announces U.S. FDA Fast Track Designation for KT-621, A First-In-Class, Oral Stat6 Degrader for the Treatment of Moderate to Severe Asthma	CI

c6db9c.pZPDJlKcmN43QL3x9qLilBcjzTuBouulT6dK7OWkxvc.wdCnUgil75NNbe_Cv8GR8nxtuG-xloD0DeQvtq7xt5yS4YpXENP8rwAohQ

Published financial data: KYMERA THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	72.83M	46.83M	78.59M	47.07M	39.21M
Total Revenues	72.83M	46.83M	78.59M	47.07M	39.21M
Cost of Goods Sold, Total	137M	164M	189M	240M	317M
Gross Profit	-64.18M	-117M	-110M	-193M	-277M
Selling General & Admin Expenses, Total	36.34M	43.83M	55.04M	63.53M	68.19M
Other Operating Expenses, Total	36.34M	43.83M	55.04M	63.53M	68.19M
Operating Income	-101M	-161M	-166M	-257M	-346M
Interest Expense, Total	-175K	-176K	-196K	-249K	-370K
Interest And Investment Income	488K	6.62M	18.76M	38.03M	38.42M
Net Interest Expenses	313K	6.45M	18.57M	37.78M	38.05M
EBT, Excl. Unusual Items	-100M	-155M	-147M	-219M	-307M
Asset Writedown	-	-	-	-4.92M	-3.86M
EBT, Incl. Unusual Items	-100M	-155M	-147M	-224M	-311M
Earnings From Continuing Operations	-100M	-155M	-147M	-224M	-311M
Net Income to Company	-100M	-155M	-147M	-224M	-311M
Net Income - (IS)	-100M	-155M	-147M	-224M	-311M
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-100M	-155M	-147M	-224M	-311M
Net Income to Common Excl. Extra Items	-100M	-155M	-147M	-224M	-311M
Per Share Items
Net EPS - Basic	-2.09	-2.87	-2.52	-2.98	-3.69
Basic EPS - Continuing Operations	-2.09	-2.87	-2.52	-2.98	-3.69
Basic Weighted Average Shares Outstanding	47.99M	53.93M	58.37M	75.04M	84.49M
Net EPS - Diluted	-2.09	-2.87	-2.52	-2.98	-3.69
Diluted EPS - Continuing Operations	-2.09	-2.87	-2.52	-2.98	-3.69
Diluted Weighted Average Shares Outstanding	47.99M	53.93M	58.37M	75.04M	84.49M
Normalized Basic EPS	-1.31	-1.79	-1.57	-1.82	-2.27
Normalized Diluted EPS	-1.31	-1.79	-1.57	-1.82	-2.27
Supplemental Items
EBITDA	-99.03M	-159M	-163M	-251M	-339M
EBITA	-101M	-161M	-166M	-257M	-346M
EBIT	-101M	-161M	-166M	-257M	-346M
EBITDAR	-95.92M	-156M	-153M	-236M	-323M
Normalized Net Income	-62.64M	-96.76M	-91.85M	-137M	-192M
Interest on Long-Term Debt	158K	179K	181K	206K	312K
Supplemental Operating Expense Items
General and Administrative Expenses	36.34M	43.83M	55.04M	63.53M	68.19M
Research And Development Expense From Footnotes	137M	164M	189M	240M	317M
Net Rental Expense, Total	3.11M	3.29M	10.87M	15.05M	15.87M
Imputed Operating Lease Interest Expense	242K	262K	334K	348K	552K
Imputed Operating Lease Depreciation	2.87M	3.02M	10.53M	14.71M	15.32M
Stock-Based Comp., COGS (Total)	11.73M	18.01M	21.56M	27.77M	31.52M
Stock-Based Comp., G&A Exp. (Total)	13.24M	17.47M	21.56M	27.25M	28.38M
Total Stock-Based Compensation	24.97M	35.48M	43.12M	55.01M	59.9M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	47.98M	68.4M	110M	120M	357M
Short Term Investments	394M	339M	265M	368M	491M
Total Cash And Short Term Investments	442M	407M	375M	489M	848M
Accounts Receivable, Total	135K	2.54M	18.76M	947K	-
Other Receivables	-	-	-	-	-
Total Receivables	135K	2.54M	18.76M	947K	-
Prepaid Expenses	8.72M	9.71M	11.67M	20.58M	22.94M
Total Current Assets	451M	419M	405M	510M	871M
Gross Property Plant And Equipment	25.22M	29.14M	112M	114M	108M
Accumulated Depreciation	-3.92M	-6.89M	-10.44M	-16.07M	-22.13M
Net Property Plant And Equipment	21.31M	22.24M	101M	97.86M	85.53M
Long-term Investments	125M	152M	61.43M	362M	771M
Other Long-Term Assets, Total	8.14M	9.15M	7.93M	7.74M	14.91M
Total Assets	606M	603M	576M	978M	1.74B
Liabilities
Accounts Payable, Total	4M	4.34M	7.08M	5.99M	4.02M
Accrued Expenses, Total	22.97M	27.5M	33.86M	34.87M	42.27M
Current Portion of Leases	3.6M	3.94M	6.34M	13.11M	13.76M
Unearned Revenue Current, Total	61.74M	35.26M	37.88M	13.58M	22.92M
Other Current Liabilities	228K	303K	524K	223K	242K
Total Current Liabilities	92.54M	71.34M	85.69M	67.77M	83.21M
Long-Term Leases	14.36M	13.39M	78.33M	74.65M	68.5M
Unearned Revenue Non Current	39.3M	28M	16.77M	-	11.44M
Other Non Current Liabilities	66K	248K	-	-	-
Total Liabilities	146M	113M	181M	142M	163M
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	5K	6K	6K	7K	8K
Additional Paid In Capital	689M	879M	926M	1.59B	2.64B
Retained Earnings	-229M	-384M	-531M	-755M	-1.07B
Comprehensive Income and Other	-660K	-4.95M	-552K	-1.48M	1.8M
Total Common Equity	460M	490M	395M	836M	1.58B
Total Equity	460M	490M	395M	836M	1.58B
Total Liabilities And Equity	606M	603M	576M	978M	1.74B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	51.67M	55.18M	61.11M	64.94M	81.64M
ECS Total Common Shares Outstanding	51.5M	55.04M	55.59M	64.89M	81.32M
Book Value / Share	8.93	8.91	7.11	12.88	19.42
Tangible Book Value	460M	490M	395M	836M	1.58B
Tangible Book Value Per Share	8.93	8.91	7.11	12.88	19.42
Total Debt	17.96M	17.34M	84.67M	87.76M	82.25M
Net Debt	-550M	-542M	-352M	-763M	-1.54B
Debt Equivalent Oper. Leases	24.88M	26.3M	86.94M	120M	127M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	4.02M	5.8M	6.74M	14.75M	15.77M
Full Time Employees	141	167	187	188	238
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-100M	-155M	-147M	-224M	-311M
Depreciation & Amortization - CF	2.4M	2.98M	3.56M	7.37M	8.31M
Depreciation & Amortization, Total	2.4M	2.98M	3.56M	7.37M	8.31M
(Gain) Loss From Sale Of Asset	18K	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	5.81M	889K	-5.23M	-13.98M	-8.88M
Asset Writedown & Restructuring Costs	-	-	-	-	3.86M
Stock-Based Compensation (CF)	24.97M	35.48M	43.12M	55.01M	59.9M
Other Operating Activities, Total	-	-	-	4.92M	-
Change In Accounts Receivable	1.3M	-2.4M	-16.23M	17.82M	947K
Change In Accounts Payable	54K	253K	2.04M	-307K	-1.97M
Change in Unearned Revenues	-69.36M	-37.77M	-8.61M	-41.08M	20.79M
Change in Other Net Operating Assets	6.08M	2.3M	25.48M	-403K	-4.5M
Cash from Operations	-129M	-153M	-103M	-195M	-233M
Capital Expenditure	-1.6M	-2.84M	-34.48M	-12.84M	-1.45M
Investment in Marketable and Equity Securities, Total	-98.24M	23.36M	174M	-391M	-520M
Cash from Investing	-99.84M	20.52M	140M	-404M	-521M
Long-Term Debt Repaid, Total	-849K	-1.13M	-76K	-1.58M	-1.49M
Total Debt Repaid	-849K	-1.13M	-76K	-1.58M	-1.49M
Issuance of Common Stock	252M	154M	4.27M	639M	1.04B
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-397K	-	-	-28.36M	-51.9M
Cash from Financing	250M	153M	4.19M	609M	991M
Net Change in Cash	21.5M	20.43M	41.25M	10.27M	237M
Supplemental Items
Cash Interest Paid	158K	179K	162K	206K	312K
Levered Free Cash Flow	-58.3M	-90.21M	-97.62M	-127M	-136M
Unlevered Free Cash Flow	-58.19M	-90.1M	-97.49M	-127M	-136M
Change In Net Working Capital	21.13M	24.94M	6.24M	15.78M	-13.39M
Net Debt Issued / Repaid	-849K	-1.13M	-76K	-1.58M	-1.49M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-11.5	-16.67	-17.55	-20.65	-15.87
Return on Total Capital	-16.12	-20.46	-20.96	-22.87	-16.71
Return On Equity %	-26.96	-32.6	-33.21	-36.38	-25.78
Return on Common Equity	-26.96	-32.6	-33.21	-36.38	-25.78
Margin Analysis
Gross Profit Margin %	-88.13	-250.76	-140.59	-410.38	-707.34
SG&A Margin	49.9	93.61	70.03	134.97	173.9
EBITDA Margin %	-135.97	-340.58	-207.99	-532.67	-864.12
EBITA Margin %	-138.03	-344.37	-210.62	-545.36	-881.24
EBIT Margin %	-138.03	-344.37	-210.62	-545.36	-881.24
Income From Continuing Operations Margin %	-137.6	-330.6	-186.99	-475.56	-794.04
Net Income Margin %	-137.6	-330.6	-186.99	-475.56	-794.04
Net Avail. For Common Margin %	-137.6	-330.6	-186.99	-475.56	-794.04
Normalized Net Income Margin	-86	-206.63	-116.87	-290.69	-490.13
Levered Free Cash Flow Margin	-80.05	-192.65	-124.21	-269.44	-346.95
Unlevered Free Cash Flow Margin	-79.9	-192.42	-124.05	-269.11	-346.36
Asset Turnover
Asset Turnover	0.13	0.08	0.13	0.06	0.03
Fixed Assets Turnover	3.47	2.15	1.27	0.47	0.43
Receivables Turnover (Average Receivables)	92.9	35.05	7.38	4.78	-
Short Term Liquidity
Current Ratio	4.88	5.88	4.73	7.53	10.47
Quick Ratio	4.78	5.74	4.59	7.23	10.19
Operating Cash Flow to Current Liabilities	-1.39	-2.15	-1.2	-2.87	-2.8
Days Sales Outstanding (Average Receivables)	3.93	10.41	49.46	76.62	-
Average Days Payable Outstanding	11.15	9.27	11.01	9.95	5.77
Long Term Solvency
Total Debt/Equity	3.91	3.54	21.44	10.5	5.21
Total Debt / Total Capital	3.76	3.42	17.65	9.5	4.95
LT Debt/Equity	3.12	2.73	19.83	8.93	4.34
Long-Term Debt / Total Capital	3.01	2.64	16.33	8.08	4.12
Total Liabilities / Total Assets	24.14	18.73	31.4	14.56	9.36
EBIT / Interest Expense	-574.46	-916.23	-844.54	-1.03K	-933.9
EBITDA / Interest Expense	-548.13	-887.45	-778.56	-946.52	-872.87
(EBITDA - Capex) / Interest Expense	-557.26	-903.57	-954.47	-998.08	-876.79
Total Debt / EBITDA	-0.19	-0.11	-0.55	-0.37	-0.25
Net Debt / EBITDA	5.73	3.47	2.3	3.24	4.76
Total Debt / (EBITDA - Capex)	-0.18	-0.11	-0.45	-0.35	-0.25
Net Debt / (EBITDA - Capex)	5.64	3.41	1.88	3.07	4.74
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	114	-35.71	67.84	-40.11	-16.7
Gross Profit, 1 Yr. Growth %	128.65	82.94	-5.9	74.84	43.58
EBITDA, 1 Yr. Growth %	118.9	61.04	2.5	53.39	35.13
EBITA, 1 Yr. Growth %	117.11	60.41	2.65	55.08	34.6
EBIT, 1 Yr. Growth %	117.11	60.41	2.65	55.08	34.6
Earnings From Cont. Operations, 1 Yr. Growth %	119.81	54.47	-5.07	52.32	39.08
Net Income, 1 Yr. Growth %	119.81	54.47	-5.07	52.32	39.08
Normalized Net Income, 1 Yr. Growth %	119.81	54.47	-5.07	48.97	40.45
Diluted EPS Before Extra, 1 Yr. Growth %	-33.69	37.45	-12.28	18.47	23.53
Accounts Receivable, 1 Yr. Growth %	-90.58	1.78K	639.53	-94.95	-
Net Property, Plant and Equip., 1 Yr. Growth %	3	4.39	354.43	-3.18	-12.61
Total Assets, 1 Yr. Growth %	24.37	-0.46	-4.54	69.87	78.2
Tangible Book Value, 1 Yr. Growth %	61.91	6.64	-19.42	111.56	89.04
Common Equity, 1 Yr. Growth %	61.91	6.64	-19.42	111.56	89.04
Cash From Operations, 1 Yr. Growth %	-246.31	18.72	-32.83	89.16	19.74
Capital Expenditures, 1 Yr. Growth %	-82.44	77.58	1.12K	-62.77	-88.71
Levered Free Cash Flow, 1 Yr. Growth %	-246.63	54.74	8.21	29.93	7.26
Unlevered Free Cash Flow, 1 Yr. Growth %	-246.09	54.84	8.2	29.93	7.21
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	398.23	17.3	3.88	0.26	-29.37
Gross Profit, 2 Yr. CAGR %	36.95	104.52	31.2	28.26	58.44
EBITDA, 2 Yr. CAGR %	53.96	87.75	28.48	25.39	43.97
EBITA, 2 Yr. CAGR %	54.34	86.62	28.32	26.17	44.48
EBIT, 2 Yr. CAGR %	54.34	86.62	28.32	26.17	44.48
Earnings From Cont. Operations, 2 Yr. CAGR %	55.88	84.27	21.1	20.25	45.55
Net Income, 2 Yr. CAGR %	55.88	84.27	21.1	20.25	45.55
Normalized Net Income, 2 Yr. CAGR %	55.88	84.27	21.1	18.92	44.65
Diluted EPS Before Extra, 2 Yr. CAGR %	-70.67	-4.53	9.81	1.94	20.98
Accounts Receivable, 2 Yr. CAGR %	-	33.06	1.08K	-38.9	-
Net Property, Plant and Equip., 2 Yr. CAGR %	-1.77	3.7	117.81	109.76	-8.01
Total Assets, 2 Yr. CAGR %	127.86	11.27	-2.52	27.34	73.98
Tangible Book Value, 2 Yr. CAGR %	148.54	31.4	-7.3	30.57	99.99
Common Equity, 2 Yr. CAGR %	148.54	31.4	-7.3	30.57	99.99
Cash From Operations, 2 Yr. CAGR %	168.36	31.8	-10.7	12.72	50.5
Capital Expenditures, 2 Yr. CAGR %	73.26	-44.16	364.66	112.76	-79.5
Levered Free Cash Flow, 2 Yr. CAGR %	516.86	50.63	29.4	18.57	18.05
Unlevered Free Cash Flow, 2 Yr. CAGR %	510.58	50.4	29.44	18.57	18.03
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	151.77	32.18	-13.54	-5.74
Gross Profit, 3 Yr. CAGR %	53.69	50.82	57.89	44.38	33.18
EBITDA, 3 Yr. CAGR %	67.05	56.28	53.45	36.29	28.56
EBITA, 3 Yr. CAGR %	67.35	56.33	52.9	36.68	28.92
EBIT, 3 Yr. CAGR %	67.35	56.33	52.9	36.68	28.92
Earnings From Cont. Operations, 3 Yr. CAGR %	67.13	55.41	47.72	30.72	26.23
Net Income, 3 Yr. CAGR %	67.13	55.41	47.72	30.72	26.23
Normalized Net Income, 3 Yr. CAGR %	67.13	55.41	47.72	29.75	25.7
Diluted EPS Before Extra, 3 Yr. CAGR %	-51.46	-50.92	-7.19	12.62	8.68
Accounts Receivable, 3 Yr. CAGR %	-	-	135.69	91.43	-
Net Property, Plant and Equip., 3 Yr. CAGR %	111.82	0.24	69.69	66.23	56.66
Total Assets, 3 Yr. CAGR %	139.27	72.89	5.73	17.3	42.43
Tangible Book Value, 3 Yr. CAGR %	137.21	87.46	11.64	22.05	47.71
Common Equity, 3 Yr. CAGR %	137.21	87.46	11.64	22.05	47.71
Cash From Operations, 3 Yr. CAGR %	93.26	104.48	5.28	14.68	15.01
Capital Expenditures, 3 Yr. CAGR %	5.6	74.69	55.92	100.32	-20.06
Levered Free Cash Flow, 3 Yr. CAGR %	-	289.04	34.9	29.57	14.68
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	286.48	34.77	29.6	14.66
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	74.2	2.87
Gross Profit, 5 Yr. CAGR %	-	-	44.27	41.36	58.11
EBITDA, 5 Yr. CAGR %	-	-	50.39	43.1	49.59
EBITA, 5 Yr. CAGR %	-	-	50.48	43.49	49.48
EBIT, 5 Yr. CAGR %	-	-	50.48	43.49	49.48
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	46.92	40.25	46.85
Net Income, 5 Yr. CAGR %	-	-	46.92	40.25	46.85
Normalized Net Income, 5 Yr. CAGR %	-	-	46.92	39.63	46.48
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-32.71	-34.25	3.19
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	114.19	34.68	32.83
Total Assets, 5 Yr. CAGR %	-	-	67.07	52.99	29.04
Tangible Book Value, 5 Yr. CAGR %	-	-	62.9	62.21	40.96
Common Equity, 5 Yr. CAGR %	-	-	62.9	62.21	40.96
Cash From Operations, 5 Yr. CAGR %	-	-	41.92	61.13	21.45
Capital Expenditures, 5 Yr. CAGR %	-	-	91.01	89.02	-30.75
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	141.87	27.89
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	140.92	27.8